Heated Humidified Oxygen Compared to Dry Oxygen Therapy in Children With Bronchiolitis
NCT ID: NCT02094664
Last Updated: 2018-01-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2014-01-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypotheses are that heating and humidifying inspired low flow supplemental oxygen will optimize mucociliary function thereby, 1) improve oxygenation, 2) decrease work of breathing, and 3) decrease length of hospital stay.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Oxygen Therapy in Bronchiolitis
NCT01216553
Treatment Of Bronchiolitis With Heated Humidified High Flow Nasal Cannula - Prospective And Retrospective Research
NCT02366715
High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis
NCT02856165
Study of High-flow Oxygen Therapy Against Standard Therapy in Bronchiolitis
NCT01498094
Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia
NCT01662544
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The airways normally heat and humidify inspired ambient air to core temperature amd 100% relative humidity at the carina. This environment, at core temperature, allows for optimal mucociliary clearance. Supplemental oxygen delivered via wall source is cold and dry, and does not reach core temperature and 100% humidity until some point distal to the carina, past the main bronchi. This presses on the lower respiratory tract to assist in heat and moisture exchange and thus decrease ciliary function. This, in combination with bronchiolitis, can impair mucociliary clearance.
Specific aim 1: Determine the effect of heated and humidified oxygen therapy on clinical improvement in children with bronchiolitis, based on Respiratory Distress Assessment Instrument (RDAI) and respiratory rate (RR).
Specific aim 2: Determine the effect of heated and humidified oxygen therapy on length of hospital stay and duration of supplemental oxygen requirement in children with bronchiolitis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard oxygen via nasal cannula
Standard therapy
No interventions assigned to this group
Heated and humidified oxygen
Heated and humified oxygen
Heated and humidified oxygen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heated and humidified oxygen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physician diagnosed bronchiolitis
* Admitted to pediatric floor
* Supplemental oxygen requirement, \<4 L/min, for hypoxemia, oxygen saturation \<92% in room air
Exclusion Criteria
* Admitted to pediatric intensive care unit for medical indication
* Requirement of heated, humidified high flow system
* Chronic lung disease (such as bronchopulmonary dysplasia, cystic fibrosis, primary ciliary dyskinesia, tracheostomy status, baseline oxygen requirement)
* Neuromuscular disorders
* Chromosomal defects
* Metabolic disorders
* Immunodeficiency
* Unrepaired cardiac abnormalities
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UCSF Benioff Children's Hospital Oakland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diana Chen
Pediatric Pulmonary Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diana Chen, M.D.
Role: PRINCIPAL_INVESTIGATOR
UCSF Benioff Children's Hospital Oakland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital and Research Center Oakland
Oakland, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.